Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy

By Karlsdottir Asa   Muren Ludvig Paul   Wentzel-Larsen Tore   Johannessen Dag   Haukaas Svein Andreas   Halvorsen Ole Johan   Dahl Olav  

Acta Oncologica, Vol. 48, Iss. 6, 2009-08 ,pp. : 874-881

Informa Healthcare

Access to resources Recommend Favorite

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

By Zelefsky M.J.   Fuks Z.   Hunt M.   Yamada Y.   Marion C.   Ling C.C.   Amols H.   Venkatraman E.S.   Leibel S.A.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 306-307

Elsevier

Access to resources Recommend Favorite

Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy

By Hong Theodore   Tomé Wolfgang   Jaradat Hazim   Raisbeck Bridget   Ritter Mark  

Acta Oncologica, Vol. 45, Iss. 6, 2006-09 ,pp. : 717-727

Informa Healthcare

Access to resources Recommend Favorite

Hazards of dose escalation in prostate cancer radiotherapy

By Kuban D.   Pollack A.   Huang E.   Levy L.   Dong L.   Starkschall G.   Rosen I.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1260-1268

Elsevier

Access to resources Recommend Favorite

Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy

By Symon Z.   Griffith K.A.   McLaughlin P.W.   Sullivan M.   Sandler H.M.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 384-390

Elsevier

Access to resources Recommend Favorite